Capanovi SAS is a French headquarted company, created by Dr Olivier de Masfrand. It created the
Vocalyx communication solution for mutes and individuals with speech language disorders.

Capanovi is currently doing a second round of funding to strengthen its staff, infrastructure and
international development.

The investment benefits from several tax advantages.

Capanovi is currently on the Smartangels equity-crowdfunding platform.


Labelled Innovative Company and supported by Oseo BPI, Capanovi activated the research tax credit between 2012 and 2014.

Speech Language disorders, notably aphasia, affect 450 000 people in France and over 10 Millions worldwide.

Capanovi lies at the crossroads between healthcare, digital, disabilities and social innovation.